Maxcyte MXCT Cash Flow Statement (2020-2026)

NASDAQ MXCT
$1.18 +0.02 (+1.72%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Maxcyte Quarterly Cash Flow Statement

Periods 25 quarters
Latest Jun 2026

Maxcyte reported cash from operations of -$4.66M and free cash flow of -$4.72M for the quarter ended Jun 2026, up 52.7% year over year. This cash flow statement covers 25 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-2.68M-4.87M-4.07M-8.26M-6.43M-4.81M-10.88M-10.51M-11.25M-5.28M-9.53M-9.38M-11.56M-10.60M-10.26M-12.36M-12.42M-9.60M-4.75M-8.87M
Depreciation and Depletion
1.08M1.07M1.06M1.09M1.09M1.06M1.05M1.03M0.96M
Share-based Compensation
2.29M2.45M2.46M2.97M3.20M3.12M3.28M3.52M3.61M3.57M3.02M3.56M3.37M3.13M3.04M3.51M1.95M0.71M1.14M1.16M
Gains from Sales and Divestitures
0.00M-0.01M-0.01M-0.03M-0.10M-0.40M-0.05M-0.07M-0.02M-0.15M
Asset Writedowns and Impairment
0.70M0.94M0.07M0.36M3.03M0.20M0.63M
Cash from Operations
-0.69M-0.96M-3.69M0.92M-5.92M-6.09M-4.32M-10.11M-8.24M0.98M-10.56M-4.83M-4.39M-7.82M-14.41M-9.85M-7.46M-2.69M-8.17M-4.66M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Depreciation & Amortization
0.37M0.42M0.49M0.55M0.74M0.92M0.96M1.03M1.08M1.10M1.11M1.08M1.07M1.06M1.10M1.10M1.07M1.07M1.05M0.98M
Change in Working Capital
Change in Receivables
0.24M0.92M1.75M-1.19M900.004.01M-3.40M-0.59M0.42M-1.66M0.34M-1.67M-0.02M0.12M0.84M0.24M2.57M-4.80M0.74M-0.32M
Change in Inventory
0.12M1.11M1.38M1.26M0.24M0.61M1.71M0.84M1.55M0.45M-0.17M-0.66M-0.00M-0.53M-0.53M-0.22M0.11M0.07M0.38M0.47M
Change in Accured Expenses
0.56M2.52M-0.15M1.09M0.22M-1.31M1.23M-2.27M2.56M1.73M-3.29M-0.21M2.08M-0.46M-5.59M0.25M2.00M-0.38M-3.64M0.36M
Other Working Capital Changes
0.63M1.34M7.57M1.24M0.53M-3.86M-0.96M-1.06M0.89M-0.52M-0.69M-1.01M3.29M-2.29M-1.33M-1.50M1.89M-0.74M-0.46M-0.68M
Investing Activities
Capital Expenditures
1.44M1.12M6.00M6.81M3.48M2.19M1.56M0.51M0.72M0.92M0.80M0.29M0.41M0.15M0.65M0.58M0.30M0.23M0.07M0.06M
Sales of Property, Plant and Equipment
0.01M
Change in Intangibles
0.15M
Acquisitions
1.77M
Cash from Investing Activities
-162.35M-11.44M194.80M-131.85M-60.67M-27.09M29.64M26.67M2.81M-4.14M-14.40M19.39M3.61M-1.67M9.53M1.54M5.19M9.68M2.66M6.57M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt Repayments
Change in Capital Stock
Net Equity Issued and Repurchased
184.27M-51.81M0.89M0.33M0.44M1.23M1.46M0.16M0.04M0.22M0.70M0.45M0.23M0.22M0.38M0.02M0.01M0.01M0.01M0.03M
Misc.
Cash from Financing Activities
184.59M1.21M0.89M0.33M0.44M1.23M1.46M0.16M0.04M0.49M0.70M0.71M0.23M0.41M0.38M0.15M0.01M0.10M0.01M-1.42M
Change in Cash
21.55M-11.19M191.99M-130.61M-66.15M-31.96M26.77M16.72M-5.39M-2.67M-24.26M15.26M-0.56M-9.07M-4.50M-8.16M-2.25M7.09M-5.51M0.48M
Free Cash Flow
-2.13M-2.08M-9.69M-5.89M-9.40M-8.28M-5.88M-10.61M-8.96M0.07M-11.37M-5.13M-4.80M-7.97M-15.06M-10.44M-7.76M-2.92M-8.24M-4.72M
Net Cash Flow
21.55M-11.19M191.99M-130.61M-66.15M-31.96M26.77M16.72M-5.39M-2.67M-24.26M15.26M-0.56M-9.07M-4.50M-8.16M-2.25M7.09M-5.51M0.48M

Maxcyte Cash Flow Statement API

Pull Maxcyte's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=MXCT&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY